Abstract
A quality management system (QMS) is an integrated framework through which organizations can systematically plan and achieve their quality objectives. While the International Conference on Harmonisation (ICH) Q10 provides clear guidance for QMS in the pharmaceutical manufacturing sector, there is no harmonized regulatory guidance describing a framework that provides an enterprise-wide view of achievement of clinical quality objectives, that is capable of being customized to fit an organization’s unique circumstances, and that accommodates the variability inherent in clinical development. In the absence of such guidance, clinical QMS varies dramatically across industry, sometimes resulting in over-engineered, cumbersome systems that are not adaptable or fit-for-purpose. This paper will describe the ongoing activities of a TransCelerate initiative developing a conceptual framework for a Clinical QMS designed to provide a consistent, streamlined, and proactive quality approach across all stages of clinical research.
Article PDF
Avoid common mistakes on your manuscript.
References
Forbes Insights. Culture of quality: accelerating grown and performance in the enterprise. http://www.forbes.com/forbesinsights/asq/index.html. Accessed April 8, 2015.
International Conference on Harmonisation (ICH). ICH Harmonised Tripartite Guideline: Pharmaceutical Quality System Q10 (current step 4 version). June 4, 2008.
Woodcock J. Quality risk management in clinical trials. Expert meeting presentation at: Developing Effective Quality Systems in Clinical Trials: An Enlightened Approach. A Clinical Trials Transformation Initiative (CTTI)-Sponsored Meeting; October 13–14, 2010; Bethesda, MD.
Kleppinger CF, Ball LK. Building quality in clinical trials with use of a quality systems approach. Clin Infect Dis. 2010;51(S1): S111–S116.
Medicines and Healthcare Products Regulatory Agency (MHRA). Quality systems [chapter 14]. In: MHRA. Good Clinical Practice Guide. London: MHRA; 2012:440–441.
Food and Drug Administration (FDA). Guidance for Industry: Oversight of Clinical Investigations—A Risk-Based Approach to Monitoring. Silver Spring, MD: FDA; 2013.
European Medicines Agency (EMA). Reflection Paper on Risk Based Quality Management in Clinical Trials. London: EMA; 2013.
Clinical Trials Transformation Initiative (CTTI). CTTI recommendations: effective and efficient monitoring as a component of quality assurance in the conduct of clinical trials. Durham, NC: CTTI; 2011.
International Organization for Standardization, ISO 9001: 2015, Quality Management Systems. http://www.iso.org/iso/iso9001_revision. Accessed April 22, 2015.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Meeker-O’Connell, A., Borda, M.M., Little, J.A. et al. Enhancing Quality and Efficiency in Clinical Development Through a Clinical QMS Conceptual Framework: Concept Paper Vision and Outline. Ther Innov Regul Sci 49, 615–622 (2015). https://doi.org/10.1177/2168479015596018
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1177/2168479015596018